AXA Framlington Health Fund - R Income

Category Sector Equity Healthcare


star-filledstar-filledstar-filledstar-filled
Last buy/sell price

3,164.00p

arrow-down-5.00p (-0.16%)

Fund Code

0575371

GB0005753719

Prices updated as at 19 Apr 2024
|
Prices in GBX

Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Fund statusOpen
Fund typeUnit Trust
Fund managerLinden Thomson, Cinney Zhang
3311
2833
Fund comparative indexMSCI World/Health Care NR GBP
Healthcare
-
1.56
0.12
-
Sector Equity Healthcare
No
Fund providerAXA Investment Managers UK Ltd
Share class launch date24 Apr 1987
£610.20m
-
-
-
Semi-Annually
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.